Effects of valproate on seizure-like activity in Drosophila melanogaster with a knockdown of Ube3a in different neuronal populations as a model of Angelman Syndrome
- PMID: 37842098
- PMCID: PMC10570944
- DOI: 10.1016/j.ebr.2023.100622
Effects of valproate on seizure-like activity in Drosophila melanogaster with a knockdown of Ube3a in different neuronal populations as a model of Angelman Syndrome
Abstract
Angelman Syndrome is a rare, genetically induced neurodevelopmental disorder. This disorder stems from a mutation or deletion of the maternal UBE3A gene. Characteristics of this disease include developmental delay, recurring seizures, and severe intellectual disabilities. We studied seizure activity in male Drosophila melanogaster with a knockdown of Ube3a in different neuronal populations (GABAergic, glutamatergic, mushroom body, and all neurons) and investigated the effects of the antiseizure medication (ASM) on seizure-like activity. Epileptiform activity was monitored in individual fruit flies using imaging chambers and mechanically induced seizures using a vortex assay. A positive control was also used: eas (easily shocked seizure phenotype). Seizure activity was analyzed for sums of seizure durations, number of seizures, and total time to return to normal activity. Ube3a knockdowns in GABAergic neurons elicited more seizure-like episodes than knockdowns in glutamatergic neurons and were on par with the positive control group and those with knockdowns in the mushroom bodies. We have established a method whereby valproate could be administered through food rather than through injections to effectively treat epileptiform activity. We demonstrated that if Ube3a is not knocked down pan-neuronally, Angelman Syndrome seizure-like activity can be studied using Drosophila melanogaster and therefore allows for high-throughput drug discovery.
Keywords: Angelman Syndrome; Drosophila melanogaster; Seizure-like activity; Valproate.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.Mol Autism. 2021 Feb 6;12(1):9. doi: 10.1186/s13229-021-00416-y. Mol Autism. 2021. PMID: 33549123 Free PMC article.
-
The fruit fly Drosophila melanogaster as a screening model for antiseizure medications.Front Pharmacol. 2024 Dec 10;15:1489888. doi: 10.3389/fphar.2024.1489888. eCollection 2024. Front Pharmacol. 2024. PMID: 39720593 Free PMC article.
-
GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.Neuron. 2016 Apr 6;90(1):56-69. doi: 10.1016/j.neuron.2016.02.040. Epub 2016 Mar 24. Neuron. 2016. PMID: 27021170 Free PMC article.
-
Towards an understanding of Angelman syndrome in mice studies.J Neurosci Res. 2020 Jun;98(6):1162-1173. doi: 10.1002/jnr.24576. Epub 2019 Dec 22. J Neurosci Res. 2020. PMID: 31867793 Review.
-
Angelman Syndrome: From Mouse Models to Therapy.Neuroscience. 2020 Oct 1;445:172-189. doi: 10.1016/j.neuroscience.2020.02.017. Epub 2020 Feb 21. Neuroscience. 2020. PMID: 32088294 Review.
Cited by
-
Exploiting fly models to investigate rare human neurological disorders.Neural Regen Res. 2025 Jan 1;20(1):21-28. doi: 10.4103/NRR.NRR-D-23-01847. Epub 2024 Apr 3. Neural Regen Res. 2025. PMID: 38767473 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Molecular Biology Databases